EUVIMEDEUVIMED entdecken
Crossref

Lacidipine: Beyond Hypertension-Cardiovascular, Neuroprotective, and Renoprotective Effects

Soumarshi Das, Prabir Maity, Anjali Sharma, Sarita Jangra

Journal of Pharmaceutical Technology, Research and Management · 29.01.2026 · 13 (2) · 1-21

DOI: 10.15415/jptrm.2025.132001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Technology, Research and Management, online erschienen am 29.01.2026. Verfasst von Soumarshi Das und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension remains a leading contributor to cardiovascular, cerebrovascular, and renal disease worldwide. While calcium channel blockers are well established for blood pressure management, growing attention is being given to agents that provide organ protection beyond hemodynamic control. Lacidipine, a highly lipophilic dihydropyridine calcium channel blocker, shows strong membrane affinity and antioxidant properties, suggesting potential benefits that extend beyond its antihypertensive role.

Purpose

This review critically examines lacidipine’s therapeutic profile by integrating evidence of its vascular, cardiovascular, neurovascular, and renal protective effects alongside its established clinical use.

Methods

A comprehensive analysis of preclinical studies, clinical trials, and mechanistic reports was conducted to examine lacidipine’s pharmacological properties, antioxidant activity, and vasoprotective roles beyond blood pressure control.

Results

Lacidipine exhibits pronounced vascular selectivity and sustained activity with good tolerability in clinical use. Experimental studies demonstrate antioxidant and anti-inflammatory effects that mitigate endothelial dysfunction, vascular remodeling, and oxidative injury. Clinical evidence supports its efficacy is comparable to other major antihypertensive classes. Emerging data further indicate neuroprotective effects in models of stroke and neurodegeneration, renoprotective actions through improved microvascular and glomerular function, and cardioprotective benefits including attenuation of left ventricular hypertrophy and atherosclerotic progression.

Conclusions

Beyond effective blood pressure management, lacidipine shows multi organ protective properties that may enhance long term outcomes in hypertension associated disorders. Further studies are warranted to validate these benefits in clinical settings and to explore repositioning strategies that leverage its pleiotropic therapeutic potential.

Zitieren

APA

Das, S., Maity, P., Sharma, A., & Jangra, S. (2026). Lacidipine: Beyond Hypertension-Cardiovascular, Neuroprotective, and Renoprotective Effects. Journal of Pharmaceutical Technology, Research and Management, 13(2), 1-21. https://doi.org/10.15415/jptrm.2025.132001

Vancouver

Das S, Maity P, Sharma A, Jangra S. Lacidipine: Beyond Hypertension-Cardiovascular, Neuroprotective, and Renoprotective Effects. Journal of Pharmaceutical Technology, Research and Management. 2026;13(2):1-21. doi:10.15415/jptrm.2025.132001

BibTeX
@article{Das2026,
  author = {Das, Soumarshi and Maity, Prabir and Sharma, Anjali and Jangra, Sarita},
  title = {Lacidipine: Beyond Hypertension-Cardiovascular, Neuroprotective, and Renoprotective Effects},
  journal = {Journal of Pharmaceutical Technology, Research and Management},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {1--21},
  doi = {10.15415/jptrm.2025.132001}
}
Kostenlos starten →